Canthaxanthin (CID 5281227) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(1)
 
 
Inactive(142)
 
 
Inconclusive(8)
 
 
Unspecified(1)
 
 
Top Targets:
Menin(2)
 
 
NR LBD ROR li..(2)
 
 
Peptidase C1A(2)
 
 
 
NR LBD TR(2)
 
 
HELICc(2)
 
 
BioAssay Types:
Confirmatory(75)
 
 
 
Literature(62)
 
 
 
 
Screening(5)
 
 
BioActivity Types:
Potency(73)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 91    Data Row: 152   Total Pages: 4   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID48415687]
 DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
2
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View
3
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_1, Type: Literature]
View
4
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_2, Type: Literature]
View
5
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature]
View
6
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_4, Type: Literature]
View
7
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_5, Type: Literature]
View
8
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_6, Type: Literature]
View
9
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_7, Type: Literature]
View
10
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_8, Type: Literature]
View
11
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_9, Type: Literature]
View
12
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_10, Type: Literature]
View
13
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_11, Type: Literature]
View
14
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_12, Type: Literature]
View
15
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_13, Type: Literature]
View
16
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_14, Type: Literature]
View
17
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_15, Type: Literature]
View
18
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_16, Type: Literature]
View
19
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_17, Type: Literature]
View
20
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_18, Type: Literature]
View
21
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_19, Type: Literature]
View
22
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_20, Type: Literature]
View
23
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_21, Type: Literature]
View
24
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_22, Type: Literature]
View
25
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_26, Type: Literature]
View
26
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_27, Type: Literature]
View
27
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_28, Type: Literature]
View
28
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_29, Type: Literature]
View
29
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_30, Type: Literature]
View
30
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_31, Type: Literature]
View
31
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_32, Type: Literature]
View
32
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_33, Type: Literature]
View
33
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_34, Type: Literature]
View
34
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_35, Type: Literature]
View
35
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_36, Type: Literature]
View
36
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_37, Type: Literature]
View
37
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_38, Type: Literature]
View
38
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_39, Type: Literature]
View
39
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_40, Type: Literature]
View
40
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_41, Type: Literature]
View
41
[SID26749913]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_42, Type: Literature]
View
42
[SID26749913]
Potency S16 Schwann cell viability assay (CellTiter-Glo assay) [AID624031, Type: confirmatory]
View
43
[SID92308891]
 A screen for compounds that inhibit liver stage malaria [AID624349, Type: other]
View
44
[SID144205086]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]
View
45
[SID144205086]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]
View
46
[SID144205086]
 qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening]
View
47
[SID92308891]
 A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus [AID651828, Type: other]Nucleoprotein [gi:127925]
View
48
[SID26749913]
Potency Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory]Luciferase [Photinus pyralis] [gi:160794]
View
49
[SID26749913]
Potency Counterscreen for Luciferase (Kinase-Glo TM) Inhibition [AID1379, Type: confirmatory]luciferase [Photuris pennsylvanica] [gi:1669525]
View
50
[SID26749913]
Potency qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View